SCHEMBL7793709

SCHEMBL7793709

CCCC(=S)C(CCCCC(=O)OC)CCC(C)=O

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.40
TSHR P16473 3/20 0.40
PPARG P37231 2/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
BIRC2 Q13490 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
SLC1A1 P43005 1/20 0.35
PPARA Q07869 1/20 0.34
EPHX2 P34913 1/20 0.34
PLA2G2A P14555 2/20 0.33
PABPC1 P11940 1/20 0.33
APOBEC3A P31941 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7793674 0.88 L3MBTL1 (0.40) L3MBTL1TSHRPPARGCA1CA2
SCHEMBL7784255 0.85 L3MBTL1 (0.40) L3MBTL1TSHRPPARGCA1CA2
SCHEMBL8103007 0.83 FFAR4 (0.45) TSHRPPARGALDH1A1PPARA
SCHEMBL7784246 0.79 L3MBTL1 (0.40) L3MBTL1TSHRPPARGCA1CA2
SCHEMBL8104827 0.74 TSHR (0.48) L3MBTL1TSHRPPARGALDH1A1LMNA
SCHEMBL7784250 0.74 LMNA (0.51) TSHRALDH1A1LMNA
SCHEMBL7792778 0.74 CTSK (0.32) TSHRLMNAEPHX2
SCHEMBL7794222 0.73 DGKA (0.45) L3MBTL1TSHRALDH1A1LMNAPLA2G2A
SCHEMBL7793707 0.72 TSHR (0.39) L3MBTL1TSHRPPARGALDH1A1LMNA
SCHEMBL22122660 0.71 TSHR (0.58) TSHRCA2ALDH1A1LMNAEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0947503-B1 6,8-Dimethylmercaptooctanoic acid derivatives substituted on 6-S and/or 8-S by the 3-methylthiopropanoyl radical and pharmaceutical compositions for the treatment of cancerous tumours GALDERMA RES & DEV (FR) 2001-11-21 EP claimed
US-6117902-A 6,8-dimercaptooctanoic acid derivatives substituted at the 6-S and/or 8-S position with the (3-methylthiopropanoyl) radical and pharmaceutical compositions intended for the treatment of cancerous tumors GALDERMAN RESEARCH & DEVELOPMENT, S.N.C. SOPHIA ABTIPOLIS (FR) 2000-09-12 US disclosed